E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/24/2011 in the Prospect News Convertibles Daily and Prospect News Liability Management Daily.

Safeguard Scientifics investors put nearly all of 2.625% convertibles

By Susanna Moon

Chicago, March 24 - Safeguard Scientifics, Inc. said investors put $30.85 million of its $31.3 million outstanding 2.625% convertible senior debentures due 2024 at par on March 21.

The repurchase reduced the company's debt-to-equity ratio to 1:5 from 1:3 as of Dec. 31 and from 1:2 as of Dec. 31, 2009, according to a company press release.

The company issued $150 million of the 2.625% convertibles in 2004. From 2006 through 2009, the company repurchased $71.8 million at an average 21% discount to face value.

In March some Safeguard institutional investors exchanged $46.9 million of the 2.625% convertibles for a like amount of new 10.125% debentures due 2014 with an effective conversion price of $16.50.

"The repurchase improves Safeguard's financial strength and flexibility at a time when we are working with partner companies to drive aggressive growth, achieve solid risk-adjusted returns from well-timed exit transactions, and evaluate opportunities to deploy capital in more high-potential businesses," Peter J. Boni, president and chief executive officer, said in the release.

Safeguard said on March 4 that it expected holders to put the entire $31.3 million outstanding amount of the 2.625% convertibles.

The adjusted conversion price was $43.3044 per share. The company's common stock closed at $20.35 (NYSE: SFE) on March 3.

Safeguard Scientific is a technology incubator based in Wayne, Pa.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.